These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 9519744)

  • 1. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
    Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM
    Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
    Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
    J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
    Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
    J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes.
    Cusi KJ; Pratipanawatr T; Koval J; Printz R; Ardehali H; Granner DK; Defronzo RA; Mandarino LJ
    Metabolism; 2001 May; 50(5):602-6. PubMed ID: 11319725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of hexokinase II expression in human skeletal muscle in vivo.
    Vogt C; Ardehali H; Iozzo P; Yki-Järvinen H; Koval J; Maezono K; Pendergrass M; Printz R; Granner D; DeFronzo R; Mandarino L
    Metabolism; 2000 Jun; 49(6):814-8. PubMed ID: 10877213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
    Mandarino LJ; Consoli A; Jain A; Kelley DE
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
    Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H
    Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM.
    Laakso M; Edelman SV; Brechtel G; Baron AD
    Diabetes; 1992 Sep; 41(9):1076-83. PubMed ID: 1499861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
    Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
    Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
    Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
    J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
    Simoneau JA; Kelley DE
    J Appl Physiol (1985); 1997 Jul; 83(1):166-71. PubMed ID: 9216960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
    Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A
    Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
    Vestergaard H; Lund S; Bjørbaek C; Pedersen O
    Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.
    Damsbo P; Vaag A; Hother-Nielsen O; Beck-Nielsen H
    Diabetologia; 1991 Apr; 34(4):239-45. PubMed ID: 1906024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis.
    Iozzo P; Pratipanawatr T; Pijl H; Vogt C; Kumar V; Pipek R; Matsuda M; Mandarino LJ; Cusi KJ; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2001 May; 280(5):E712-9. PubMed ID: 11287353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.